Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6692)
All Articles published online
|
Publishing Process of This Article
|
Oct 14, 2014 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Elimova E, Shiozaki H, Wadhwa R, Sudo K, Chen Q, Estrella JS, Blum MA, Badgwell B, Das P, Song S, Ajani JA. Medical management of gastric cancer: A 2014 update. World J Gastroenterol 2014; 20(38): 13637-13647 [PMID: 25320502 DOI: 10.3748/wjg.v20.i38.13637] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v20/i38/13637.htm |
| Number | Citing Articles |
| 1 |
Kei Muro, Hyun Cheol Chung, Veena Shankaran, Ravit Geva, Daniel Catenacci, Shilpa Gupta, Joseph Paul Eder, Talia Golan, Dung T Le, Barbara Burtness, Autumn J McRee, Chia-Chi Lin, Kumudu Pathiraja, Jared Lunceford, Kenneth Emancipator, Jonathan Juco, Minori Koshiji, Yung-Jue Bang. Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial. The Lancet Oncology 2016; 17(6): 717 doi: 10.1016/S1470-2045(16)00175-3
|
| 2 |
Guoxiu Wang, Jiuda Zhao, Yan Song, Wen Zhang, Yongkun Sun, Aiping Zhou, Jing Huang, Feng Du, Lin Yang. Phase II study of adjuvant chemotherapy with S1 plus oxaliplatin for Chinese patients with gastric cancer. BMC Cancer 2018; 18(1) doi: 10.1186/s12885-018-4480-9
|
| 3 |
Dilsa Mizrak Kaya, Kazuto Harada, Jaffer A. Ajani. Is targeted therapy possible for patients with gastric adenocarcinoma?. Expert Opinion on Pharmacotherapy 2016; 17(18): 2371 doi: 10.1080/14656566.2016.1236917
|
| 4 |
Jill P. Smith, Sandeep Nadella, Nick Osborne. Gastrin and Gastric Cancer. Cellular and Molecular Gastroenterology and Hepatology 2017; 4(1): 75 doi: 10.1016/j.jcmgh.2017.03.004
|
| 5 |
Wareeporn Wattanawongdon, Theeraya Simawaranon Bartpho, Taweesak Tongtawee, Rosario Caltabiano. Expression of Matrix Metalloproteinase-7 Predicts Poor Prognosis in Gastric Cancer. BioMed Research International 2022; 2022: 1 doi: 10.1155/2022/2300979
|
| 6 |
P.T.P. Kaumaya, T. Bekaii-Saab. Comprehensive Medicinal Chemistry III. 2017; : 1 doi: 10.1016/B978-0-12-409547-2.12422-9
|
| 7 |
Jie Shen, Jia Wei, Wenxian Guan, Hao Wang, Yitao Ding, Xiaoping Qian, Lixia Yu, Zhengyun Zou, Li Xie, Carlota Costa, Trever Bivona, Rafael Rosell, Baorui Liu. Plasma mRNA expression levels of BRCA1 and TS as potential predictive biomarkers for chemotherapy in gastric cancer. Journal of Translational Medicine 2014; 12(1) doi: 10.1186/s12967-014-0355-2
|
| 8 |
Hamit Basaran, Timur Koca, Arda Kaymak Cerkesli, Deniz Arslan, Sibel Karaca. Treatment Outcomes and Survival Study of Gastric Cancer Patients: A Retrospective Analysis in an Endemic Region. Asian Pacific Journal of Cancer Prevention 2015; 16(5): 2055 doi: 10.7314/APJCP.2015.16.5.2055
|
| 9 |
Lu Gan, Midie Xu, Ruixi Hua, Cong Tan, Jieyun Zhang, Yiwei Gong, Zhenhua Wu, Weiwei Weng, Weiqi Sheng, Weijian Guo. The polycomb group protein EZH2 induces epithelial–mesenchymal transition and pluripotent phenotype of gastric cancer cells by binding to PTEN promoter. Journal of Hematology & Oncology 2018; 11(1) doi: 10.1186/s13045-017-0547-3
|
| 10 |
Catherine M. Clavel, Patrycja Nowak-Sliwinska, Emilia Păunescu, Paul J. Dyson. Thermoresponsive fluorinated small-molecule drugs: a new concept for efficient localized chemotherapy. MedChemComm 2015; 6(12): 2054 doi: 10.1039/C5MD00409H
|
| 11 |
|
| 12 |
Lanshan Huang, Fanghui Ren, Ruixue Tang, Zhenbo Feng, Gang Chen. Prognostic Value of Expression of Cyclin E in Gastrointestinal Cancer. Technology in Cancer Research & Treatment 2016; 15(1): 12 doi: 10.1177/1533034614568098
|
| 13 |
Edoardo Virgilio, Enrico Giarnieri, Monica Montagnini, Rosaria D’Urso, Antonella Proietti, Alessandra Mesiti, Maria Rosaria Giovagnoli, Paolo Mercantini, Marco Cavallini, Genoveffa Balducci. Detection of cancer cells and tumor markers in gastric lavage of patients with gastric cancer: Do these findings have a clinicopathological significance and oncological implication?. Medical Hypotheses 2016; 94: 1 doi: 10.1016/j.mehy.2016.06.010
|
| 14 |
Boutayeb Saber. Long Survival with Metronomic Therapy for Heavily Pretreated Advanced Gastric Cancer: Case Report. MOJ Clinical & Medical Case Reports 2015; 2(4) doi: 10.15406/mojcr.2015.02.00029
|
| 15 |
Edoardo Virgilio, Enrico Giarnieri, Monica Montagnini, Rosaria D''Urso, Antonella Proietti, Alessandra Mesiti, Maria Rosaria Giovagnoli, Paolo Mercantini, Marco Cavallini, Genoveffa Balducci. Analyzing Gastric Lavage of Gastric Cancer Patients: A Prospective Observational Study on Cytopathology and Determination of Intragastric CEA, CA 19.9, CA 72.4, and CA 50. Acta Cytologica 2016; 60(2): 161 doi: 10.1159/000445765
|
| 16 |
Gebra Cuyun Carter, Anna Kaltenboeck, Jasmina Ivanova, Astra M. Liepa, Alexandra San Roman, Maria Koh, Narayan Rajan, Rebecca Cheng, Howard G. Birnbaum, Jong Seok Kim, Yung-Jue Bang. Real-World Treatment Patterns among Patients with Advanced Gastric Cancer in South Korea. Cancer Research and Treatment 2017; 49(3): 578 doi: 10.4143/crt.2016.001
|
| 17 |
Pathmanathan Rajadurai, Ho Kean Fatt, Foo Yoke Ching. Prevalence of HER2 Positivity and Its Clinicopathological Correlation in Locally Advanced/Metastatic Gastric Cancer Patients in Malaysia. Journal of Gastrointestinal Cancer 2018; 49(2): 150 doi: 10.1007/s12029-017-9921-1
|
| 18 |
Nandie Wu, Ying Huang, Zhengyun Zou, Ana Gimenez-Capitan, Lixia Yu, Wenjing Hu, Lijing Zhu, Xia Sun, Jose Javier Sanchez, Wenxian Guan, Baorui Liu, Rafael Rosell, Jia Wei. High BIM mRNA levels are associated with longer survival in advanced gastric cancer. Oncology Letters 2017; 13(3): 1826 doi: 10.3892/ol.2017.5660
|
| 19 |
Brian Badgwell, Mariela Blum, Elena Elimova, Jeannelyn Estrella, Yi-Ju Chiang, Prajnan Das, Paul Mansfield, Jaffer Ajani. Frequency of Resection After Preoperative Chemotherapy or Chemoradiotherapy for Gastric Adenocarcinoma. Annals of Surgical Oncology 2016; 23(6): 1948 doi: 10.1245/s10434-016-5112-8
|
| 20 |
Roberto Petrioli, Giandomenico Roviello, Laura Zanotti, Franco Roviello, Karol Polom, Alberto Bottini, Luigi Marano, Edoardo Francini, Daniele Marrelli, Daniele Generali. Epirubicin-based compared with docetaxel-based chemotherapy for advanced gastric carcinoma: A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology 2016; 102: 82 doi: 10.1016/j.critrevonc.2016.04.001
|
| 21 |
Akira Okita, Hiroo Imai, Masahiro Takahashi, Hidekazu Takahashi, Sho Umegaki, Yoshifumi Kawamura, Sakura Hiraide, Kota Ouchi, Yuko Sato, Yoshinari Okada, Keigo Komine, Ken Saijo, Shin Takahashi, Masanobu Takahashi, Hidekazu Shirota, Hisatsugu Ohori, Makio Gamoh, Chikashi Ishioka. Efficacy and Safety of Trastuzumab in Combination with S-1 and Cisplatin Therapy for Japanese Patients with HER2-Positive Advanced Gastric Cancer: Retrospective Analysis. The Tohoku Journal of Experimental Medicine 2018; 245(2): 123 doi: 10.1620/tjem.245.123
|
| 22 |
R. Hofheinz, J. Clouth, J. Borchardt-Wagner, U. Wagner, E. Weidling, M. H. Jen, P. Brück. Patient preferences for palliative treatment of locally advanced or metastatic gastric cancer and adenocarcinoma of the gastroesophageal junction: a choice-based conjoint analysis study from Germany. BMC Cancer 2016; 16(1) doi: 10.1186/s12885-016-2975-9
|
| 23 |
Shima Abed, Kaveh Baghaei, Parviz Pakzad, Mehrdad Hashemi, Mohammad Reza Zali. Evaluation of Epithelial-Mesenchymal Transition Genes Involved in Iranian Gastric Cancer Patients via Transcriptome Analysis. International Journal of Cancer Management 2019; (In Press) doi: 10.5812/ijcm.94924
|
| 24 |
Jie Sun, Junjie Piao, Nan Li, Yang Yang, Ki‐Yeol Kim, Zhenhua Lin. Valproic acid targets HDAC1/2 and HDAC1/PTEN/Akt signalling to inhibit cell proliferation via the induction of autophagy in gastric cancer. The FEBS Journal 2020; 287(10): 2118 doi: 10.1111/febs.15122
|
| 25 |
Carles Pericay, Fernando Rivera, Carlos Gomez‐Martin, Inmaculada Nuñez, Alejo Cassinello, Esteban Rodrigo Imedio. Positioning of second‐line treatment for advanced gastric and gastroesophageal junction adenocarcinoma. Cancer Medicine 2016; 5(12): 3464 doi: 10.1002/cam4.941
|
| 26 |
Jill P. Smith, Hong Cao, Wenqiang Chen, Kanwal Mahmood, Teresa Phillips, Lynda Sutton, Allen Cato. Gastrin Vaccine Alone and in Combination With an Immune Checkpoint Antibody Inhibits Growth and Metastases of Gastric Cancer. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.788875
|
| 27 |
Zongchang Song, Chunliang Guo, Lu Zhu, Pinying Shen, Haitao Wang, Changsheng Guo, Jiahong Tang. Elevated expression of immunity-related GTPase family M in gastric cancer. Tumor Biology 2015; 36(7): 5591 doi: 10.1007/s13277-015-3229-1
|
| 28 |
Fangfang Chen, Shuai Yin, Li Niu, Jun Luo, Bicheng Wang, Zhigao Xu, Guifang Yang. Expression of the Chemokine Receptor CXCR3 Correlates with Dendritic Cell Recruitment and Prognosis in Gastric Cancer. Genetic Testing and Molecular Biomarkers 2018; 22(1): 35 doi: 10.1089/gtmb.2017.0125
|
| 29 |
Kotoe Takayoshi, Keita Uchino, Masahiro Nakano, Koji Ikejiri, Eishi Baba. Weight Loss During Initial Chemotherapy Predicts Survival in Patients With Advanced Gastric Cancer. Nutrition and Cancer 2017; 69(3): 408 doi: 10.1080/01635581.2017.1267774
|